EC Number |
Inhibitors |
Structure |
---|
3.1.4.53 | (-)-6-(3-(3-cyclopropyl-3-((1R,2R)-2-hydroxycyclohexyl)ureido)-propoxy)-2(1H)-quinolinone |
IC50: 0.1195 mM, PDE7 |
|
3.1.4.53 | (2E)-9,10-dimethoxy-3-methyl-2-[(2,4,6-trimethylphenyl)imino]-2,3,6,7-tetrahydro-4H-pyrimido[6,1-a]isoquinolin-4-one |
- |
|
3.1.4.53 | (2R,3R)-3-(6-amino-9H-purin-9-yl)nonan-2-ol |
IC50: 0.31 mM, PDE4 |
|
3.1.4.53 | (2Z)-9,10-dimethoxy-3-methyl-2-[(2,4,6-trimethylphenyl)imino]-2,3,6,7-tetrahydro-4H-pyrimido[6,1-a]isoquinolin-4-one |
IC50: 0.00043 mM, PDE4 |
|
3.1.4.53 | (4aS,8aR)-4-(3,4-dimethoxyphenyl)-4a,5,8,8a-tetrahydrophthalazin-1(2H)-one |
- |
|
3.1.4.53 | (R)-rolipram |
- |
|
3.1.4.53 | 1,10-phenanthroline |
0.3 mM, more than 95% inhibition |
|
3.1.4.53 | 1-(2,4-dichlorobenzyl)-7-(2-oxopropyl)-3-propyl-3,7-dihydro-1H-purine-2,6-dione |
- |
|
3.1.4.53 | 1-(2-methylbenzyl)-3-propyl-3,7-dihydro-1H-purine-2,6-dione |
- |
|
3.1.4.53 | 1-(2-methylbenzyl)-7-(2-oxopropyl)-3-propyl-3,7-dihydro-1H-purine-2,6-dione |
- |
|